New laser trial aims to zap away redness and birthmarks
NCT ID NCT07290426
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test a special laser called the Vbeam Pro on 40 adults with rosacea or port-wine stain birthmarks. The goal is to see if the laser can safely clear or improve these red skin conditions. Participants will receive laser treatments and be evaluated for changes in appearance and satisfaction.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Vbeam Pro Laser System (pulse dye laser)
- What this could lead to
- If successful, this could provide a safe, effective laser option to reduce redness and improve the appearance of rosacea and port-wine stains.
- What could go wrong
- This is a small, early-stage study with no control group, so results may not apply broadly. Laser treatments can cause temporary bruising, swelling, or discomfort.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Mar 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Healthy subjects aged 18 years or older 2. Presence of one or more vascular lesion, cutaneous lesion, or other dermatological condition deemed fit for treatment 3. Able and willing to comply with the treatment/follow-up schedule and comply with all study (protocol) requirements. 4. Willing to provide signed, informed consent to participate in the study 5. Willing to have photographs and images taken of the treated areas to be used in evaluations, publications, presentations, and marketing materials Exclusion Criteria: 1. Pregnant or planning to become pregnant, having given birth less than 3 months prior to enrollment into the study, and/or breast feeding 2. Known photosensitivity to 595nm or 1064 nm light 3. History of light-induced seizure disorders 4. Severe unstable concurrent conditions, such as unstable cardiac disorders 5. Use of implanted medical device including pacemakers, cardioverters and other implantable devices or fillers per investigator discretion (consultation with physicians prior to treatment is required) 6. Use of photosensitizing medications (medications that introduce photosensitivity or medications within or above the 595 nm wavelength, refer to Candela's list of drugs that may cause photosensitivity) 7. Tattoos (including decorative, permanent makeup and radiation port tattoos) in the intended study treatment area (595nm use only) 8. Active Herpes Simplex Virus (HSV) in the intended treatment area unless treated with prophylactic medication 9. The intended treatment area has significant sun exposure within the past 2 weeks or self-tanner has been applied to the treatment area 10. In the opinion of the Investigator, the subject is unwilling or unable to adhere to the study requirements or is otherwise unsuitable for the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Port-wine stain are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a quieter, automated blood pressure check help more people control hypertension?
- Inhaled drug aims to ease dangerous lung blood pressure in scarred lungs
- Can a generic cream match Brand-Name rosacea treatments?
- Can we predict the path of chronic skin disease?
- Can lifestyle choices after a stroke extend life and prevent a second one?
- Could a phone app help parents of kids with special needs thrive?